158 related articles for article (PubMed ID: 11782694)
1. Naftidrofuryl in quality of life (NIQOL). A Belgian study.
D'Hooge D; Lehert P; Clement DL
Int Angiol; 2001 Dec; 20(4):288-94. PubMed ID: 11782694
[TBL] [Abstract][Full Text] [Related]
2. Naftidrofuryl can enhance the quality of life in patients with intermittent claudication.
Spengel F; Brown TM; Poth J; Lehert P
Vasa; 1999 Aug; 28(3):207-12. PubMed ID: 10483329
[TBL] [Abstract][Full Text] [Related]
3. Findings of the Naftidrofuryl in Quality of Life (NIQOL) European study program.
Spengel F; Clément D; Boccalon H; Liard F; Brown T; Lehert P
Int Angiol; 2002 Mar; 21(1):20-7. PubMed ID: 11941270
[TBL] [Abstract][Full Text] [Related]
4. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
Kieffer E; Bahnini A; Mouren X; Gamand S
Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
[TBL] [Abstract][Full Text] [Related]
5. Treatment of stage II chronic arterial disease of the lower limbs with the serotonergic antagonist naftidrofuryl: results after 6 months of a controlled, multicenter study.
Adhoute G; Andreassian B; Boccalon H; Cloarec M; Di Maria G; Lefebvre O; Mondine P; Plagnol P; Pointel JP; Quancard X
J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S75-80. PubMed ID: 1369725
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of patients with severe intermittent claudication and the effect of treatment with naftidrofuryl.
Moody AP; al-Khaffaf HS; Lehert P; Harris PL; Charlesworth D
J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S44-7. PubMed ID: 7517477
[TBL] [Abstract][Full Text] [Related]
7. [Double-blind randomized comparative study of nicergoline naftidrofuryl on the quality of life in chronic obliterative arteriopathy of lower limbs with intermittent claudication].
Meilhac B; Montestruc F; Aubin F; Djian F; Rouffy J
Therapie; 1997; 52(3):179-86. PubMed ID: 9366101
[TBL] [Abstract][Full Text] [Related]
8. Naftidrofuryl in intermittent claudication: a retrospective analysis.
Lehert P; Comte S; Gamand S; Brown TM
J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S48-52. PubMed ID: 7517478
[TBL] [Abstract][Full Text] [Related]
9. [Intermittent claudication and quality of life. Psychometric validation of the French version of the CLAU-S questionnaire].
Boccalon H; Lehert P; Comte S
J Mal Vasc; 2000 Apr; 25(2):98-107. PubMed ID: 10804390
[TBL] [Abstract][Full Text] [Related]
10. Naftidrofuryl: a review of its use in the treatment of intermittent claudication.
Goldsmith DR; Wellington K
Drugs Aging; 2005; 22(11):967-77. PubMed ID: 16323973
[TBL] [Abstract][Full Text] [Related]
11. The effect of naftidrofuryl on intermittent claudication: a meta-analysis.
Lehert P; Riphagen FE; Gamand S
J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S81-6. PubMed ID: 1369727
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the efficacy and tolerance of naftidrofuryl in patients presenting with exertional angina. Multicenter double-blind versus placebo study].
Hirsch JL; Bensoussan JJ; Mosnier M; Lehert P
Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):137-45. PubMed ID: 12555338
[TBL] [Abstract][Full Text] [Related]
13. [Consequences of obliterating arteriopathy of the legs on the professional activity of patients and external assistance].
Rolland N; Lebrun T; Comte S; Sailly JC
J Mal Vasc; 1999 Jun; 24(3):208-13. PubMed ID: 10467531
[TBL] [Abstract][Full Text] [Related]
14. Naftidrofuryl for intermittent claudication.
de Backer TL; Vander Stichele R; Lehert P; Van Bortel L
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD001368. PubMed ID: 23235580
[TBL] [Abstract][Full Text] [Related]
15. Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data.
De Backer T; Vander Stichele R; Lehert P; Van Bortel L
BMJ; 2009 Mar; 338():b603. PubMed ID: 19276131
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of iloprost in patients with intermittent claudication.
Creager MA; Pande RL; Hiatt WR
Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
Messa GL; Gelso E
Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
[TBL] [Abstract][Full Text] [Related]
18. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
Nenci GG; Gresele P; Ferrari G; Santoro L; Gianese F;
Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
[TBL] [Abstract][Full Text] [Related]
19. Naftidrofuryl for intermittent claudication.
De Backer TL; Vander Stichele R; Lehert P; Van Bortel L
Cochrane Database Syst Rev; 2008 Apr; (2):CD001368. PubMed ID: 18425872
[TBL] [Abstract][Full Text] [Related]
20. Naftidrofuryl in chronic arterial disease. Results of a six month controlled multicenter study using Naftidrofuryl tablets 200 mg.
Adhoute G; Bacourt F; Barral M; Cardon JM; Chevalier JM; Cuny A; Gillet M; Juhan C; Leguay G; Marion J
Angiology; 1986 Mar; 37(3 Pt 1):160-7. PubMed ID: 3518547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]